Juliet Dizon

Juliet Dizon is an experienced professional in the field of clinical quality assurance and compliance, currently serving as the Director of Global Research and Development Quality Clinical Auditing at Bristol Myers Squibb since May 2021. Prior to this role, Juliet held various leadership positions at Actelion (now Janssen Pulmonary Hypertension), where responsibilities included program lead for PAH risk management and associate director for GCP quality assurance. Juliet's extensive background also includes significant roles at Johnson & Johnson, Merck Sharp & Dohme, and Novartis, focusing on clinical project management, GCP auditing, and quality control in clinical research. Juliet holds a Bachelor of Science in Industrial and Clinical Pharmacy from The Pontifical and Royal Catholic University of Santo Tomas.